THE TRUTH ABOUT: 3 - Caught on Camera

Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?

Nektar Therapeutics soared 157% after Rezpeg succeeded in a Phase 2b eczema trial. Analysts forecast huge upside—here’s why there could be more gains ahead.

MarketBeat · Jun 28, 2025

How having a pet dog can alter some children’s immune systems

IN FULL

The Independent UK · Jun 4, 2025

Study shows what a pet dog can do to save your child’s skin from eczema

Academics said that having a pet dog in early life could have a ‘protective effect’

The Independent UK · Jun 4, 2025

Is it true that … showering every day is bad for your skin?

Does the length of time you stand in the water make a difference? And what about the temperature?

The Guardian - UK · Mar 31, 2025

First Nations Australians are more likely to present to hospital with asthma and allergies – new research

Australia is often called the allergy capital of the world. Allergic diseases – such as allergic asthma, hay fever, eczema and food allergies – affect almost one in five people. And this figure is expected to rise in the years to come.

The Conversation · Mar 18, 2025

Air pollution linked to eczema – new research

If you live in a city or near a busy road, it might not just be your lungs bearing the brunt of air pollution – your skin could be suffering too. A recent study has found a significant link between high levels of fine particulate matter (PM2.5) and incidence of…

The Conversation · Nov 20, 2024

Can frequent baths give babies eczema? Trial examines how often to wash your newborn

London scientists hope findings will help children with the skin condition

Evening Standard · Nov 1, 2024

Woman Suspects Hubby Turned On Soft Water To “Test” Her Eczema, Worries About Her Marriage

Husband turns on soft water despite knowing it makes his wife's eczema worse, says he wanted to see if it was "in her head." The post Woman Suspects Hubby Turned On Soft Water To “Test” Her Eczema, Worries About Her Marriage first appeared on Bored Panda.

Bored Panda · Oct 31, 2024

Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval?

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

StockNews.com · Oct 23, 2024

London hospital launches study to prevent food allergies through eczema treatment

Results of study could have ‘hugely significant impact’ and halve allergy rates

Evening Standard · Oct 8, 2024